Free Trial

Aramark (ARMK) Financials

Aramark logo
$51.27 +0.01 (+0.01%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$51.26 -0.01 (-0.01%)
As of 05/22/2026 07:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Aramark

Annual Income Statements for Aramark

This table shows Aramark's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/2/2015 9/30/2016 9/29/2017 9/28/2018 9/27/2019 10/2/2020 10/1/2021 9/30/2022 9/29/2023 9/27/2024 10/3/2025
Net Income / (Loss) Attributable to Common Shareholders
236 288 374 568 449 -462 -91 195 675 263 326
Consolidated Net Income / (Loss)
237 288 374 568 448 -461 -92 194 674 263 326
Net Income / (Loss) Continuing Operations
237 288 374 568 15,417 -461 -92 39 447 262 327
Total Pre-Tax Income
342 431 521 472 556 -648 -133 47 564 365 430
Total Operating Income
628 746 802 818 891 -265 191 415 625 707 792
Total Gross Profit
1,449 1,525 1,609 1,792 16,227 836 1,089 1,072 1,309 1,426 1,547
Total Revenue
14,329 14,416 14,604 15,790 16,227 12,830 12,096 13,687 16,083 17,401 18,506
Operating Revenue
14,329 14,416 14,604 15,790 16,227 12,830 12,096 13,687 16,083 17,401 18,506
Total Cost of Revenue
12,880 12,890 12,995 13,998 0.00 11,994 11,007 12,616 14,775 15,975 16,960
Operating Cost of Revenue
12,880 12,890 12,995 13,998 - 11,994 11,007 12,616 14,775 15,975 16,960
Total Operating Expenses
821 779 807 973 367 1,101 897 656 684 719 755
Selling, General & Admin Expense
317 283 299 377 367 307 347 258 274 284 278
Depreciation Expense
504 496 508 596 - 595 551 398 410 436 476
Total Other Income / (Expense), net
-286 -315 -281 -347 -335 -383 -324 -368 -62 -342 -361
Interest & Investment Income
- - - - 0.00 0.00 138 -368 -437 -367 -342
Other Income / (Expense), net
- - 0.00 - 0.00 0.00 -61 0.00 376 25 -19
Income Tax Expense
105 143 146 -97 108 -186 -41 8.43 116 103 104
Net Income / (Loss) Discontinued Operations
- - - - - - - 155 226 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
1.03 0.43 0.26 0.56 -0.08 0.09 -1.39 -0.31 -0.58 -0.63 0.48
Basic Earnings per Share
$0.99 $1.19 $1.53 $2.31 - ($1.83) ($0.36) $0.76 $2.59 $1.00 $1.24
Weighted Average Basic Shares Outstanding
237.62M 242.29M 244.45M 245.77M 246.85M 251.83M 254.75M 257.31M 260.59M 263.05M 263.86M
Diluted Earnings per Share
$0.96 $1.16 $1.49 $2.24 - ($1.83) ($0.36) $0.75 $2.57 $0.99 $1.22
Weighted Average Diluted Shares Outstanding
246.62M 248.76M 251.56M 253.35M 252.01M 251.83M 254.75M 259.07M 262.59M 266.20M 267.35M
Weighted Average Basic & Diluted Shares Outstanding
238.30M 244.75M 245.04M 246.73M 249.43M 253.14M 256.04M 258.74M 261.51M 263.95M 262.93M
Cash Dividends to Common per Share
- - - - $0.44 $0.44 $0.44 $0.44 $0.44 $0.38 $0.42

Quarterly Income Statements for Aramark

This table shows Aramark's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/29/2023 12/29/2023 3/29/2024 6/28/2024 9/27/2024 12/27/2024 3/28/2025 6/27/2025 10/3/2025 1/2/2026 4/3/2026
Net Income / (Loss) Attributable to Common Shareholders
206 29 53 58 123 106 62 72 87 96 102
Consolidated Net Income / (Loss)
203 29 53 58 122 106 62 72 87 97 102
Net Income / (Loss) Continuing Operations
108 29 53 58 122 106 62 72 87 97 102
Total Pre-Tax Income
105 52 73 80 160 141 84 96 108 136 138
Total Operating Income
215 167 159 162 219 217 174 183 218 218 220
Total Gross Profit
393 4,408 4,200 335 397 4,552 360 4,626 -7,992 4,832 426
Total Revenue
4,200 4,408 4,200 4,376 4,417 4,552 4,279 4,626 5,048 4,832 4,907
Operating Revenue
4,200 4,408 4,200 4,376 4,417 4,552 4,279 4,626 5,048 4,832 4,907
Total Cost of Revenue
3,807 0.00 0.00 4,041 4,020 0.00 3,920 0.00 13,040 0.00 4,481
Operating Cost of Revenue
3,807 - - 4,041 4,020 - 3,920 - - - 4,481
Total Operating Expenses
178 4,241 4,041 174 178 4,335 185 4,444 -8,209 4,614 207
Selling, General & Admin Expense
75 90 63 65 65 70 68 66 74 73 74
Depreciation Expense
103 106 109 108 113 113 117 122 124 126 132
Total Other Income / (Expense), net
-111 -115 -86 -81 -59 -76 -90 -86 -109 -82 -82
Interest & Investment Income
- -115 -86 -81 - -76 -90 -86 -90 -82 -82
Income Tax Expense
-3.55 24 20 22 37 36 22 24 21 39 35
Net Income / (Loss) Attributable to Noncontrolling Interest
0.01 -0.02 -0.45 -0.01 -0.16 0.08 0.12 0.17 0.10 0.34 0.19
Basic Earnings per Share
$0.79 $0.11 $0.20 $0.22 $0.47 $0.40 $0.23 $0.27 $0.33 $0.37 $0.39
Weighted Average Basic Shares Outstanding
260.59M 262.05M 262.84M 263.39M 263.05M 264.88M 264.81M 262.66M 263.86M 263.13M 263.16M
Diluted Earnings per Share
$0.79 $0.11 $0.20 $0.22 $0.47 $0.39 $0.23 $0.27 $0.33 $0.36 $0.38
Weighted Average Diluted Shares Outstanding
262.59M 264.29M 265.28M 266.58M 266.20M 268.69M 267.42M 265.35M 267.35M 266.35M 266.39M
Weighted Average Basic & Diluted Shares Outstanding
261.51M 262.45M 262.99M 263.45M 263.95M 265.10M 262.07M 262.85M 262.93M 262.84M 262.95M
Cash Dividends to Common per Share
$0.11 $0.10 $0.10 $0.10 $0.10 $0.11 $0.11 $0.11 $0.10 $0.12 $0.12

Annual Cash Flow Statements for Aramark

This table details how cash moves in and out of Aramark's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/2/2015 9/30/2016 9/29/2017 9/28/2018 9/27/2019 10/2/2020 10/1/2021 9/30/2022 9/29/2023 9/27/2024 10/3/2025
Net Change in Cash & Equivalents
11 30 86 -24 32 2,263 -1,977 -222 1,643 -1,240 -25
Net Cash From Operating Activities
802 867 1,053 1,052 984 177 657 464 512 727 921
Net Cash From Continuing Operating Activities
802 867 1,053 1,052 984 177 657 464 512 727 921
Net Income / (Loss) Continuing Operations
237 288 374 568 448 -461 -92 39 447 262 327
Depreciation Expense
504 496 508 596 593 595 551 398 410 436 476
Non-Cash Adjustments To Reconcile Net Income
66 57 65 88 -124 245 -107 25 -486 -92 -25
Changes in Operating Assets and Liabilities, net
-5.23 26 105 -201 67 -202 306 1.72 141 121 143
Net Cash From Investing Activities
-504 -680 -678 -2,865 -210 -361 -634 -745 224 -416 -722
Net Cash From Continuing Investing Activities
-504 -680 -678 -2,865 -210 -361 -634 -745 224 -416 -722
Purchase of Property, Plant & Equipment
-524 -546 -555 -912 -503 -419 -408 -312 -384 -427 -489
Acquisitions
-3.38 -177 -148 -1,995 -45 -22 -266 -387 -54 -183 -289
Purchase of Investments
- - - - - 0.00 0.00 -78 -110 -113 0.00
Sale of Property, Plant & Equipment
19 27 19 10 18 54 32 16 18 24 23
Sale and/or Maturity of Investments
- - - - - - 0.00 0.00 713 288 44
Other Investing Activities, net
4.30 5.34 -2.54 -6.88 27 26 6.72 16 40 -3.76 -10
Net Cash From Financing Activities
-287 -157 -289 1,794 -735 2,438 -2,005 -35 663 -1,561 -235
Net Cash From Continuing Financing Activities
-287 -157 -289 1,794 -735 2,438 -2,005 -35 660 -1,561 -235
Repayment of Debt
-267 -1,500 -3,968 -1,277 -693 -1,090 -2,513 -64 -1,884 -2,042 -1,932
Repurchase of Common Equity
-50 -0.75 -100 -24 -50 -6.54 - - -24 -14 -170
Payment of Dividends
-82 -92 -101 -103 -108 -111 -112 -113 -115 -100 -111
Issuance of Debt
72 1,400 3,851 3,177 78 3,555 578 100 1,182 571 1,968
Issuance of Common Equity
40 36 29 22 39 90 42 43 46 37 43
Other Financing Activities, net
- - - - - - - 0.00 1,455 -13 -34
Effect of Exchange Rate Changes
- - 0.56 - - - - -29 - - 11
Other Net Changes in Cash
- - - -4.52 -8.20 9.46 6.05 123 248 11 0.00

Quarterly Cash Flow Statements for Aramark

This table details how cash moves in and out of Aramark's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/29/2023 12/29/2023 3/29/2024 6/28/2024 9/27/2024 12/27/2024 3/28/2025 6/27/2025 10/3/2025 1/2/2026 4/3/2026
Net Change in Cash & Equivalents
1,561 -1,629 70 81 237 -194 436 -416 149 -199 32
Net Cash From Operating Activities
927 -657 221 141 1,022 -587 256 77 1,176 -782 400
Net Cash From Continuing Operating Activities
927 -657 221 141 1,022 -587 256 77 1,176 -782 400
Net Income / (Loss) Continuing Operations
108 29 53 58 122 106 62 72 87 97 102
Consolidated Net Income / (Loss)
- 29 - - - 106 62 72 - 97 102
Depreciation Expense
103 106 109 108 113 113 117 122 124 126 132
Non-Cash Adjustments To Reconcile Net Income
6.13 -31 -38 8.19 -22 -46 -10 1.82 30 -79 -31
Changes in Operating Assets and Liabilities, net
709 -760 97 -34 809 -760 87 -119 934 -926 197
Net Cash From Investing Activities
-100 -198 -92 -90 -36 -231 -252 -132 -108 -154 -163
Net Cash From Continuing Investing Activities
-100 -198 -92 -90 -36 -231 -252 -132 -108 -154 -163
Purchase of Property, Plant & Equipment
-125 -116 -87 -85 -139 -120 -116 -111 -142 -122 -101
Acquisitions
-4.69 -83 -9.40 -14 -77 -111 -136 -15 -26 -33 -72
Sale of Property, Plant & Equipment
5.10 4.42 6.37 6.44 6.72 2.07 1.10 1.15 18 2.12 6.43
Other Investing Activities, net
25 -3.45 -1.41 2.70 -1.60 -1.69 -0.50 -6.24 -1.92 -0.93 4.00
Net Cash From Financing Activities
583 -779 -54 32 -761 643 424 -387 -914 736 -203
Net Cash From Continuing Financing Activities
583 -779 -54 32 -761 643 424 -387 -914 736 -203
Repayment of Debt
-583 -987 -31 -31 -1,020 508 -1,952 -452 -5.91 599 -551
Repurchase of Common Equity
- - - - - -29 - -31 -30 -41 -25
Payment of Dividends
-29 -25 -25 -25 -25 -28 -28 -28 -28 -32 -32
Issuance of Debt
-264 228 -8.99 79 273 181 2,508 103 -824 233 395
Issuance of Common Equity
3.26 4.50 11 9.29 12 12 4.40 20 6.55 3.20 16
Other Financing Activities, net
- - - - - -1.20 - - - -27 -6.63
Cash Interest Paid
- 111 84 72 - 65 96 66 - 70 88
Cash Income Taxes Paid
- 45 32 13 - 11 70 29 - 23 23

Annual Balance Sheets for Aramark

This table presents Aramark's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/2/2015 9/30/2016 9/29/2017 9/28/2018 9/27/2019 10/2/2020 10/1/2021 9/30/2022 9/29/2023 9/27/2024 10/3/2025
Total Assets
10,196 10,582 11,006 13,720 13,736 15,713 14,376 15,082 16,871 12,674 13,305
Total Current Assets
2,379 2,493 2,653 2,901 2,658 4,676 2,899 3,292 5,220 3,407 3,523
Cash & Equivalents
122 153 239 215 247 2,509 533 329 1,927 672 639
Accounts Receivable
1,445 1,476 1,616 1,790 1,807 1,431 1,749 2,148 1,971 2,097 2,210
Inventories, net
575 587 611 725 411 436 413 552 404 388 419
Prepaid Expenses
237 276 188 171 193 299 205 262 298 250 255
Plant, Property, & Equipment, net
959 1,023 1,042 1,378 2,182 2,051 2,038 2,032 1,426 1,573 1,734
Total Noncurrent Assets
6,858 7,066 7,311 9,441 8,896 8,986 9,439 9,758 10,225 7,695 8,047
Goodwill
4,559 4,629 4,716 5,611 5,519 5,344 5,487 5,515 4,616 4,677 4,875
Intangible Assets
1,112 1,112 1,121 2,137 2,034 1,933 2,029 2,114 1,804 1,805 1,874
Other Noncurrent Operating Assets
1,187 1,326 1,475 1,693 1,344 1,710 1,923 2,130 1,301 1,213 1,299
Total Liabilities & Shareholders' Equity
10,196 10,582 11,006 13,720 13,736 15,713 14,376 15,082 16,871 12,674 13,305
Total Liabilities
8,303 8,411 8,537 10,680 10,406 12,967 11,644 12,044 13,150 9,628 10,142
Total Current Liabilities
2,181 2,185 2,368 2,490 2,705 2,347 2,857 3,286 5,030 4,214 3,547
Short-Term Debt
81 47 78 31 70 100 59 65 1,543 964 32
Accounts Payable
850 848 956 1,019 1,000 663 919 1,323 1,272 1,394 1,523
Accrued Expenses
727 776 846 1,018 1,126 940 1,135 1,172 1,288 1,283 1,390
Current Employee Benefit Liabilities
523 515 488 422 510 572 677 657 480 519 542
Other Current Liabilities
- - - - 0.00 72 67 69 51 54 61
Total Noncurrent Liabilities
6,122 6,227 6,169 8,190 7,701 10,619 8,787 8,758 8,120 5,414 6,596
Long-Term Debt
5,185 5,224 5,190 7,213 6,612 9,179 7,393 7,346 5,099 4,307 5,374
Noncurrent Deferred & Payable Income Tax Liabilities
937 1,003 979 977 1,089 1,099 1,079 1,107 411 375 411
Other Noncurrent Operating Liabilities
- - - - 0.00 342 314 306 749 731 810
Commitments & Contingencies
- - - - - 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
10 9.79 9.80 10 9.92 9.99 9.05 8.84 8.22 7.49 14
Total Equity & Noncontrolling Interests
1,883 2,161 2,459 3,030 3,320 2,736 2,723 3,030 3,713 3,039 3,148
Total Preferred & Common Equity
1,883 2,161 2,459 3,030 3,320 2,736 2,723 3,030 3,713 3,039 3,148
Total Common Equity
1,883 2,161 2,459 3,030 3,320 2,736 2,723 3,030 3,713 3,039 3,148
Common Stock
2,787 2,924 3,017 3,135 3,239 3,419 3,536 3,685 3,829 3,935 4,039
Retained Earnings
-229 -34 247 711 1,107 532 328 407 964 240 453
Treasury Stock
-509 -549 -682 -725 -809 -908 - - - - -1,177
Accumulated Other Comprehensive Income / (Loss)
-167 -181 -124 -91 -217 -307 -208 -112 -98 -132 -167

Quarterly Balance Sheets for Aramark

This table presents Aramark's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 12/30/2022 3/31/2023 6/30/2023 12/29/2023 3/29/2024 6/28/2024 12/27/2024 3/28/2025 6/27/2025 1/2/2026 4/3/2026
Total Assets
15,291 15,456 15,398 12,419 12,561 12,549 12,707 13,489 13,284 13,543 13,841
Total Current Assets
3,435 3,597 3,726 3,167 3,328 3,330 3,295 3,840 3,529 3,634 3,746
Cash & Equivalents
305 303 402 296 357 436 484 920 501 440 476
Accounts Receivable
2,300 2,354 2,406 2,199 2,221 2,200 2,201 2,232 2,357 2,496 2,475
Inventories, net
570 610 593 368 388 370 367 406 394 415 453
Prepaid Expenses
260 331 324 305 363 324 243 282 275 283 342
Plant, Property, & Equipment, net
2,032 2,015 2,037 1,490 1,491 1,494 1,603 1,650 1,702 1,773 1,786
Total Noncurrent Assets
9,823 9,844 9,634 7,762 7,742 7,725 7,809 8,000 8,053 8,136 8,308
Goodwill
5,554 5,582 5,594 4,661 4,635 4,641 4,714 4,810 4,853 4,894 4,981
Intangible Assets
2,090 2,092 2,082 1,824 1,821 1,802 1,826 1,899 1,900 1,876 1,908
Other Noncurrent Operating Assets
2,179 2,171 1,958 1,276 1,286 1,281 1,270 1,290 1,300 1,366 1,419
Total Liabilities & Shareholders' Equity
15,291 15,456 15,398 12,419 12,561 12,549 12,707 13,489 13,284 13,543 13,841
Total Liabilities
12,139 12,265 11,838 9,565 9,662 9,597 9,615 10,456 10,185 10,309 10,498
Total Current Liabilities
2,684 2,968 2,876 2,489 2,658 3,453 3,497 3,184 2,738 2,856 3,090
Short-Term Debt
103 110 111 42 42 943 943 424 41 36 34
Accounts Payable
1,093 1,138 1,049 1,096 1,097 1,042 1,105 1,135 1,138 1,280 1,246
Accrued Expenses
1,420 1,651 1,647 934 1,036 973 1,034 1,130 1,033 1,085 1,258
Current Employee Benefit Liabilities
- - - 367 433 444 361 437 465 391 486
Other Current Liabilities
69 69 70 50 50 51 54 57 61 63 65
Total Noncurrent Liabilities
9,455 9,297 8,962 7,075 7,004 6,144 6,118 7,272 7,447 7,453 7,409
Long-Term Debt
8,056 7,907 7,536 5,930 5,879 5,034 4,977 6,109 6,254 6,211 6,056
Noncurrent Deferred & Payable Income Tax Liabilities
1,097 1,080 1,122 400 390 376 397 382 372 427 463
Other Noncurrent Operating Liabilities
302 310 304 745 735 733 745 781 822 815 890
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
8.28 8.10 8.17 8.13 7.73 7.74 9.74 14 14 26 62
Total Equity & Noncontrolling Interests
3,143 3,183 3,551 2,847 2,891 2,944 3,082 3,020 3,084 3,208 3,280
Total Preferred & Common Equity
3,143 3,183 3,551 2,847 2,891 2,944 3,082 3,020 3,084 3,208 3,280
Total Common Equity
3,143 3,183 3,551 2,847 2,891 2,944 3,082 3,020 3,084 3,208 3,280
Common Stock
3,743 3,770 3,802 3,851 3,878 3,906 3,962 3,983 4,018 4,061 4,096
Retained Earnings
450 478 787 79 111 144 315 350 394 516 586
Treasury Stock
- - - - - - - - - - -1,244
Accumulated Other Comprehensive Income / (Loss)
-83 -96 -66 -89 -100 -105 -161 -166 -152 -150 -158

Annual Metrics And Ratios for Aramark

This table displays calculated financial ratios and metrics derived from Aramark's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/2/2015 9/30/2016 9/29/2017 9/28/2018 9/27/2019 10/2/2020 10/1/2021 9/30/2022 9/29/2023 9/27/2024 10/3/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-3.40% 0.61% 1.31% 8.12% 2.77% -20.94% -5.72% 13.16% 17.50% 8.19% 6.35%
EBITDA Growth
4.22% 9.73% 5.46% 8.00% 4.89% -77.74% 106.27% 19.39% 73.46% -17.28% 6.99%
EBIT Growth
11.22% 18.85% 7.41% 2.09% 8.89% -129.73% 149.29% 218.11% 140.98% -26.92% 5.58%
NOPAT Growth
18.42% 14.72% 15.42% 71.12% -27.11% -125.81% 172.27% 154.60% 45.34% 2.26% 18.57%
Net Income Growth
58.56% 21.63% 29.82% 51.91% -21.11% -202.89% 80.01% 310.89% 246.61% -61.06% 24.33%
EPS Growth
52.38% 20.83% 28.45% 50.34% 0.00% 0.00% 80.01% 310.89% 246.61% -61.48% 23.23%
Operating Cash Flow Growth
101.48% 8.12% 21.39% -0.09% -6.43% -82.05% 271.90% -29.40% 10.29% 42.00% 26.77%
Free Cash Flow Firm Growth
403.67% -46.07% 47.53% -533.00% 164.49% -93.65% -103.67% -5,250.52% 2,497.21% -85.90% -26.07%
Invested Capital Growth
-0.35% 3.57% 2.89% 34.27% -3.01% -2.56% 1.43% 4.85% -25.22% 1.02% 3.71%
Revenue Q/Q Growth
-2.73% -0.01% 0.76% 1.67% 0.23% -8.94% 7.65% -11.62% -1.17% -12.80% 3.53%
EBITDA Q/Q Growth
0.25% 2.80% 1.95% 6.87% -5.18% -47.10% 28.91% -26.18% 34.83% -22.36% -0.71%
EBIT Q/Q Growth
1.46% 5.14% 2.65% 9.12% -7.64% -853.40% 475.08% -26.15% 64.69% -22.26% -2.58%
NOPAT Q/Q Growth
2.27% 5.06% 4.43% 13.58% -13.51% -853.40% 649.91% -22.56% 9.99% -32.11% 0.95%
Net Income Q/Q Growth
5.66% 10.01% 8.63% 12.33% -16.74% -103.25% 66.52% 27.12% 23.36% -23.38% -9.96%
EPS Q/Q Growth
5.49% 9.43% 8.76% 11.44% 0.00% 0.00% 66.52% 27.12% 23.36% -24.43% -11.59%
Operating Cash Flow Q/Q Growth
39.95% -17.80% 16.21% 40.41% -11.69% -74.80% 35.39% 64.92% 21.39% -18.03% 20.07%
Free Cash Flow Firm Q/Q Growth
32.89% -51.90% 87.28% 20.78% -3.83% -89.29% 98.46% 61.34% 931.87% -85.94% 61.16%
Invested Capital Q/Q Growth
-4.60% -0.65% -2.52% -4.65% -5.45% -2.39% -2.30% -4.96% -29.95% -9.98% -10.83%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
10.11% 10.58% 11.02% 11.35% 100.00% 6.52% 9.00% 7.83% 8.14% 8.19% 8.36%
EBITDA Margin
7.90% 8.62% 8.97% 8.96% 9.14% 2.57% 5.63% 5.94% 8.77% 6.71% 6.75%
Operating Margin
4.38% 5.18% 5.49% 5.18% 5.49% -2.06% 1.58% 3.03% 3.89% 4.06% 4.28%
EBIT Margin
4.38% 5.18% 5.49% 5.18% 5.49% -2.06% 1.08% 3.03% 6.22% 4.20% 4.17%
Profit (Net Income) Margin
1.65% 2.00% 2.56% 3.60% 2.76% -3.60% -0.76% 1.42% 4.19% 1.51% 1.76%
Tax Burden Percent
69.29% 66.89% 71.87% 120.46% 80.63% 71.24% 69.41% 411.92% 119.62% 71.95% 75.83%
Interest Burden Percent
54.46% 57.74% 64.95% 57.66% 62.41% 244.50% -101.74% 11.37% 56.30% 49.87% 55.73%
Effective Tax Rate
30.71% 33.11% 28.13% -20.46% 19.37% 0.00% 0.00% 17.86% 20.66% 28.22% 24.06%
Return on Invested Capital (ROIC)
6.17% 6.97% 7.79% 11.22% 7.25% -1.92% 1.40% 3.45% 5.61% 6.67% 7.72%
ROIC Less NNEP Spread (ROIC-NNEP)
2.39% 2.86% 3.81% 4.30% 3.23% -6.10% -1.91% 1.36% 8.87% 0.87% 1.85%
Return on Net Nonoperating Assets (RNNOA)
6.92% 7.21% 8.34% 9.41% 6.84% -13.27% -4.77% 3.29% 14.34% 1.09% 2.79%
Return on Equity (ROE)
13.09% 14.18% 16.13% 20.64% 14.08% -15.19% -3.37% 6.74% 19.95% 7.76% 10.51%
Cash Return on Invested Capital (CROIC)
6.52% 3.46% 4.95% -18.04% 10.30% 0.67% -0.02% -1.29% 34.46% 5.65% 4.08%
Operating Return on Assets (OROA)
6.08% 7.18% 7.43% 6.62% 6.49% -1.80% 0.87% 2.82% 6.27% 4.95% 5.95%
Return on Assets (ROA)
2.29% 2.77% 3.47% 4.60% 3.27% -3.13% -0.61% 1.32% 4.22% 1.78% 2.51%
Return on Common Equity (ROCE)
13.02% 14.11% 16.06% 20.56% 14.04% -15.14% -3.36% 6.72% 19.90% 7.74% 10.48%
Return on Equity Simple (ROE_SIMPLE)
12.58% 13.34% 15.22% 18.76% 13.51% -16.87% -3.39% 6.42% 18.16% 8.64% 0.00%
Net Operating Profit after Tax (NOPAT)
435 499 576 986 719 -185 134 341 496 507 601
NOPAT Margin
3.04% 3.46% 3.94% 6.24% 4.43% -1.45% 1.11% 2.49% 3.08% 2.91% 3.25%
Net Nonoperating Expense Percent (NNEP)
3.78% 4.11% 3.98% 6.92% 4.01% 4.18% 3.31% 2.10% -3.26% 5.79% 5.87%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 7.03%
Cost of Revenue to Revenue
89.89% 89.42% 88.98% 88.65% 0.00% 93.48% 91.00% 92.17% 91.86% 91.81% 91.64%
SG&A Expenses to Revenue
2.21% 1.97% 2.05% 2.39% 2.26% 2.39% 2.87% 1.89% 1.70% 1.63% 1.50%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
5.73% 5.40% 5.53% 6.16% 2.26% 8.58% 7.42% 4.80% 4.25% 4.13% 4.08%
Earnings before Interest and Taxes (EBIT)
628 746 802 818 891 -265 131 415 1,001 732 772
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,132 1,242 1,310 1,415 1,484 330 681 813 1,411 1,167 1,249
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.52 3.89 3.71 3.25 3.01 2.43 3.24 2.59 2.41 3.33 3.26
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.46 0.58 0.63 0.62 0.61 0.52 0.73 0.57 0.56 0.58 0.55
Price to Earnings (P/E)
28.07 29.24 24.43 17.31 22.25 0.00 0.00 40.32 13.27 38.48 31.45
Dividend Yield
1.25% 1.10% 1.11% 1.05% 1.09% 1.68% 1.28% 1.81% 1.28% 0.99% 1.32%
Earnings Yield
3.56% 3.42% 4.09% 5.78% 4.50% 0.00% 0.00% 2.48% 7.54% 2.60% 3.18%
Enterprise Value to Invested Capital (EV/IC)
1.67 1.86 1.89 1.68 1.68 1.41 1.63 1.48 1.81 1.93 1.90
Enterprise Value to Revenue (EV/Rev)
0.82 0.94 0.97 1.07 1.01 1.05 1.30 1.09 0.85 0.85 0.81
Enterprise Value to EBITDA (EV/EBITDA)
10.40 10.90 10.82 11.93 11.07 40.63 23.10 18.37 9.69 12.62 12.04
Enterprise Value to EBIT (EV/EBIT)
18.75 18.15 17.68 20.62 18.43 0.00 120.53 35.98 13.66 20.14 19.46
Enterprise Value to NOPAT (EV/NOPAT)
27.06 27.13 24.60 17.11 22.86 0.00 117.45 43.80 27.57 29.05 25.00
Enterprise Value to Operating Cash Flow (EV/OCF)
14.68 15.62 13.46 16.04 16.69 75.96 23.95 32.21 26.72 20.28 16.32
Enterprise Value to Free Cash Flow (EV/FCFF)
25.61 54.61 38.74 0.00 16.08 207.01 0.00 0.00 4.49 34.29 47.31
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.78 2.43 2.13 2.38 2.01 3.38 2.73 2.44 1.78 1.73 1.71
Long-Term Debt to Equity
2.74 2.41 2.10 2.37 1.99 3.34 2.71 2.42 1.37 1.41 1.70
Financial Leverage
2.89 2.52 2.19 2.19 2.11 2.17 2.50 2.43 1.62 1.25 1.51
Leverage Ratio
5.70 5.11 4.65 4.49 4.31 4.85 5.49 5.11 4.73 4.37 4.18
Compound Leverage Factor
3.11 2.95 3.02 2.59 2.69 11.85 -5.59 0.58 2.66 2.18 2.33
Debt to Total Capital
73.55% 70.83% 68.09% 70.44% 66.74% 77.16% 73.17% 70.92% 64.09% 63.37% 63.09%
Short-Term Debt to Total Capital
1.14% 0.63% 1.01% 0.30% 0.70% 0.83% 0.58% 0.62% 14.89% 11.59% 0.37%
Long-Term Debt to Total Capital
72.42% 70.20% 67.08% 70.14% 66.04% 76.33% 72.60% 70.30% 49.20% 51.78% 62.73%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.14% 0.13% 0.13% 0.10% 0.10% 0.08% 0.09% 0.08% 0.08% 0.09% 0.16%
Common Equity to Total Capital
26.31% 29.04% 31.78% 29.46% 33.16% 22.75% 26.74% 28.99% 35.83% 36.54% 36.74%
Debt to EBITDA
4.65 4.24 4.02 5.12 4.50 28.09 10.94 9.11 4.71 4.52 4.33
Net Debt to EBITDA
4.54 4.12 3.84 4.97 4.34 20.50 10.16 8.71 3.34 3.94 3.82
Long-Term Debt to EBITDA
4.58 4.21 3.96 5.10 4.46 27.79 10.85 9.03 3.61 3.69 4.30
Debt to NOPAT
12.10 10.56 9.14 7.35 9.30 -50.03 55.61 21.72 13.39 10.39 8.99
Net Debt to NOPAT
11.82 10.25 8.73 7.13 8.96 -36.50 51.64 20.75 9.51 9.07 7.93
Long-Term Debt to NOPAT
11.92 10.46 9.01 7.32 9.20 -49.50 55.17 21.53 10.28 8.49 8.94
Altman Z-Score
2.08 2.23 2.27 2.01 2.08 1.29 1.36 1.43 1.65 2.14 2.23
Noncontrolling Interest Sharing Ratio
0.55% 0.49% 0.42% 0.36% 0.31% 0.33% 0.35% 0.31% 0.25% 0.23% 0.35%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.09 1.14 1.12 1.17 0.98 1.99 1.01 1.00 1.04 0.81 0.99
Quick Ratio
0.72 0.75 0.78 0.81 0.76 1.68 0.80 0.75 0.77 0.66 0.80
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
460 248 366 -1,584 1,022 65 -2.38 -127 3,048 430 318
Operating Cash Flow to CapEx
158.77% 167.21% 196.39% 116.67% 202.84% 48.48% 175.06% 156.93% 139.99% 180.06% 197.40%
Free Cash Flow to Firm to Interest Expense
1.61 0.79 1.30 -4.57 3.05 0.17 -0.01 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
2.81 2.75 3.75 3.04 2.94 0.46 1.64 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
1.04 1.11 1.84 0.43 1.49 -0.49 0.70 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.39 1.39 1.35 1.28 1.18 0.87 0.80 0.93 1.01 1.18 1.42
Accounts Receivable Turnover
9.47 9.87 9.45 9.27 9.02 7.92 7.61 7.03 7.81 8.56 8.59
Inventory Turnover
22.82 22.18 21.70 20.96 0.00 28.29 25.93 26.14 30.91 40.38 42.06
Fixed Asset Turnover
14.65 14.54 14.14 13.05 9.12 6.06 5.92 6.73 9.30 11.60 11.19
Accounts Payable Turnover
14.03 15.19 14.41 14.18 0.00 14.42 13.91 11.25 11.39 11.98 11.63
Days Sales Outstanding (DSO)
38.55 36.98 38.64 39.37 40.46 46.06 47.98 51.96 46.74 42.66 42.48
Days Inventory Outstanding (DIO)
16.00 16.46 16.82 17.41 0.00 12.90 14.08 13.96 11.81 9.04 8.68
Days Payable Outstanding (DPO)
26.02 24.03 25.33 25.75 0.00 25.30 26.24 32.43 32.05 30.46 31.39
Cash Conversion Cycle (CCC)
28.53 29.40 30.14 31.04 40.46 33.66 35.82 33.48 26.49 21.25 19.77
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
7,037 7,288 7,499 10,069 9,765 9,515 9,652 10,120 7,568 7,645 7,929
Invested Capital Turnover
2.03 2.01 1.98 1.80 1.64 1.33 1.26 1.38 1.82 2.29 2.38
Increase / (Decrease) in Invested Capital
-25 251 210 2,570 -303 -250 136 468 -2,552 77 284
Enterprise Value (EV)
11,776 13,544 14,174 16,872 16,424 13,421 15,739 14,945 13,673 14,733 15,032
Market Capitalization
6,622 8,417 9,134 9,833 9,979 6,641 8,810 7,854 8,950 10,127 10,251
Book Value per Share
$7.87 $8.86 $10.03 $12.29 $13.45 $10.82 $10.67 $11.76 $14.22 $11.54 $11.98
Tangible Book Value per Share
($15.82) ($14.68) ($13.78) ($19.14) ($17.14) ($17.95) ($18.78) ($17.85) ($10.37) ($13.07) ($13.70)
Total Capital
7,159 7,441 7,737 10,284 10,012 12,024 10,184 10,449 10,363 8,318 8,568
Total Debt
5,266 5,270 5,268 7,244 6,682 9,278 7,452 7,411 6,642 5,271 5,406
Total Long-Term Debt
5,185 5,224 5,190 7,213 6,612 9,179 7,393 7,346 5,099 4,307 5,374
Net Debt
5,144 5,117 5,030 7,029 6,436 6,769 6,920 7,081 4,715 4,599 4,767
Capital Expenditures (CapEx)
505 519 536 902 485 364 375 296 365 403 467
Debt-free, Cash-free Net Working Capital (DFCFNWC)
157 202 124 227 -224 -81 -432 -258 -194 -516 -631
Debt-free Net Working Capital (DFNWC)
280 354 363 442 23 2,428 100 71 1,733 157 7.71
Net Working Capital (NWC)
198 308 285 411 -47 2,328 41 6.10 190 -808 -24
Net Nonoperating Expense (NNE)
198 211 202 417 270 276 226 147 -178 245 275
Net Nonoperating Obligations (NNO)
5,144 5,117 5,030 7,029 6,436 6,769 6,920 7,081 3,847 4,599 4,767
Total Depreciation and Amortization (D&A)
504 496 508 596 593 595 551 398 410 436 476
Debt-free, Cash-free Net Working Capital to Revenue
1.10% 1.40% 0.85% 1.44% -1.38% -0.63% -3.57% -1.89% -1.21% -2.96% -3.41%
Debt-free Net Working Capital to Revenue
1.95% 2.46% 2.49% 2.80% 0.14% 18.93% 0.83% 0.52% 10.78% 0.90% 0.04%
Net Working Capital to Revenue
1.38% 2.14% 1.95% 2.60% -0.29% 18.15% 0.34% 0.04% 1.18% -4.64% -0.13%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.72 $0.86 $1.11 $1.67 $1.32 $0.00 $0.00 $0.55 $2.59 $1.00 $1.24
Adjusted Weighted Average Basic Shares Outstanding
328.50M 334.95M 337.95M 339.77M 341.27M 348.14M 352.18M 355.73M 260.59M 263.05M 263.86M
Adjusted Diluted Earnings per Share
$0.69 $0.84 $1.08 $1.62 $1.29 $0.00 $0.00 $0.54 $2.57 $0.99 $1.22
Adjusted Weighted Average Diluted Shares Outstanding
340.94M 343.91M 347.77M 350.25M 348.40M 348.14M 352.18M 358.16M 262.59M 266.20M 267.35M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
332.51M 338.37M 338.76M 341.10M 344.83M 349.95M 353.97M 357.71M 261.51M 263.95M 262.93M
Normalized Net Operating Profit after Tax (NOPAT)
435 499 576 573 719 -46 134 341 496 507 601
Normalized NOPAT Margin
3.04% 3.46% 3.94% 3.63% 4.43% -0.36% 1.11% 2.49% 3.08% 2.91% 3.25%
Pre Tax Income Margin
2.39% 2.99% 3.57% 2.99% 3.43% -5.05% -1.10% 0.34% 3.50% 2.10% 2.33%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.20 2.37 2.85 2.36 2.66 -0.69 0.33 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
1.52 1.58 2.05 2.85 2.15 -0.48 0.33 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.43 0.72 0.95 -0.24 1.21 -1.64 -0.61 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-0.25 -0.06 0.14 0.24 0.70 -1.44 -0.60 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
34.56% 31.95% 26.94% 18.14% 24.18% -24.03% -121.46% 58.16% 17.00% 38.05% 33.95%
Augmented Payout Ratio
55.73% 32.21% 53.67% 22.43% 35.33% -25.45% -121.46% 58.16% 17.00% 38.05% 85.98%

Quarterly Metrics And Ratios for Aramark

This table displays calculated financial ratios and metrics derived from Aramark's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/29/2023 12/29/2023 3/29/2024 6/28/2024 9/27/2024 12/27/2024 3/28/2025 6/27/2025 10/3/2025 1/2/2026 4/3/2026
DEI Shares Outstanding
- - - - - - - - - - 262,835,999.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 262,835,999.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.39
Growth Metrics
- - - - - - - - - - -
Revenue Growth
139.87% 12.62% 7.25% 7.97% 5.16% 3.27% 1.89% 5.72% 14.30% 6.14% 14.68%
EBITDA Growth
1,914.93% 7.16% 17.36% -55.75% 4.18% 21.28% 8.59% 12.82% 3.18% 3.94% 20.83%
EBIT Growth
1,562.63% 10.06% 26.91% -68.20% 1.54% 30.14% 9.48% 12.93% -0.45% 0.13% 26.17%
NOPAT Growth
2,260.15% -20.01% -22.83% 22.22% -24.75% 78.64% 10.19% 16.57% 4.64% -4.66% 27.74%
Net Income Growth
168.10% -62.72% -4.63% -82.83% -39.72% 270.67% 16.93% 23.80% -29.39% -8.71% 64.81%
EPS Growth
168.10% -60.71% -4.76% -82.95% -40.51% 254.55% 15.00% 22.73% -29.79% -7.69% 65.22%
Operating Cash Flow Growth
52.94% -6.71% -12.64% 367.64% 10.25% 10.64% 15.67% -45.50% 15.07% -33.22% 56.38%
Free Cash Flow Firm Growth
679.68% 635.29% 635.22% 4,172.76% -96.75% -93.53% -102.14% -110.79% -219.90% -316.50% -169.39%
Invested Capital Growth
-25.22% -22.48% -22.39% -21.38% 1.02% -0.04% 2.16% 4.69% 3.71% 6.03% 3.59%
Revenue Q/Q Growth
3.63% 4.94% -4.72% 4.19% 0.93% 3.06% -5.99% 8.11% 9.12% -4.30% 1.57%
EBITDA Q/Q Growth
-47.81% -14.38% -1.57% 0.60% 22.88% -0.33% -11.87% 4.52% 12.38% 0.42% 2.45%
EBIT Q/Q Growth
-57.62% -22.52% -4.71% 1.63% 35.33% -0.70% -19.83% 4.83% 19.30% -0.12% 1.01%
NOPAT Q/Q Growth
132.36% -59.20% 27.61% 1.03% 43.07% -3.15% -21.29% 6.89% 28.42% -11.75% 5.45%
Net Income Q/Q Growth
-40.00% -85.96% 87.30% 8.75% 110.60% -13.65% -41.37% 16.10% 20.59% 11.22% 5.84%
EPS Q/Q Growth
-40.00% -86.08% 81.82% 10.00% 113.64% -17.02% -41.03% 17.39% 22.22% 9.09% 5.56%
Operating Cash Flow Q/Q Growth
1,862.74% -170.91% 133.68% -36.42% 626.12% -157.47% 143.59% -70.04% 1,433.14% -166.54% 151.17%
Free Cash Flow Firm Q/Q Growth
4,755.50% -7.54% -0.29% -5.11% -96.28% 83.96% -132.93% -379.17% 58.69% -232.18% 59.03%
Invested Capital Q/Q Growth
-29.95% 12.72% -0.79% 0.35% -9.98% 11.53% 1.39% 2.84% -10.83% 14.03% -0.94%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
9.37% 100.00% 7.88% 7.66% 8.99% 100.00% 8.40% 100.00% -158.30% 100.00% 8.69%
EBITDA Margin
7.58% 6.18% 6.39% 6.17% 7.51% 7.26% 6.81% 6.58% 6.78% 7.11% 7.17%
Operating Margin
5.13% 3.79% 3.79% 3.69% 4.95% 4.77% 4.07% 3.95% 4.31% 4.50% 4.48%
EBIT Margin
5.13% 3.79% 3.79% 3.69% 4.95% 4.77% 4.07% 3.95% 4.31% 4.50% 4.48%
Profit (Net Income) Margin
4.84% 0.65% 1.27% 1.33% 2.77% 2.32% 1.45% 1.56% 1.72% 2.00% 2.08%
Tax Burden Percent
193.81% 54.43% 73.51% 72.48% 76.71% 74.72% 73.37% 74.81% 80.09% 71.15% 74.28%
Interest Burden Percent
48.63% 31.38% 45.70% 49.61% 72.93% 65.11% 48.50% 52.68% 49.74% 62.34% 62.58%
Effective Tax Rate
-3.38% 45.57% 27.10% 27.53% 23.38% 25.28% 26.63% 25.19% 19.47% 28.85% 25.72%
Return on Invested Capital (ROIC)
9.64% 3.50% 5.60% 5.54% 8.68% 7.34% 6.15% 6.07% 8.26% 6.85% 7.34%
ROIC Less NNEP Spread (ROIC-NNEP)
9.28% 2.58% 4.66% 4.61% 7.61% 6.32% 4.97% 4.93% 6.36% 5.81% 6.25%
Return on Net Nonoperating Assets (RNNOA)
15.01% 5.81% 10.15% 9.06% 9.50% 11.80% 9.37% 9.24% 9.60% 10.33% 11.00%
Return on Equity (ROE)
24.66% 9.30% 15.75% 14.60% 18.18% 19.14% 15.52% 15.31% 17.86% 17.19% 18.34%
Cash Return on Invested Capital (CROIC)
34.46% 30.41% 32.46% 31.69% 5.65% 6.67% 4.61% 2.27% 4.08% 0.89% 3.60%
Operating Return on Assets (OROA)
5.16% 4.53% 5.31% 5.28% 5.83% 6.67% 5.51% 5.46% 6.15% 6.44% 6.36%
Return on Assets (ROA)
4.87% 0.77% 1.78% 1.90% 3.26% 3.24% 1.96% 2.15% 2.45% 2.86% 2.96%
Return on Common Equity (ROCE)
24.59% 9.28% 15.71% 14.56% 18.14% 19.08% 15.47% 15.25% 17.80% 17.09% 18.12%
Return on Equity Simple (ROE_SIMPLE)
0.00% 22.00% 21.55% 11.64% 0.00% 11.02% 11.55% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
223 91 116 117 168 162 128 137 175 155 163
NOPAT Margin
5.30% 2.06% 2.76% 2.68% 3.80% 3.57% 2.99% 2.95% 3.47% 3.20% 3.33%
Net Nonoperating Expense Percent (NNEP)
0.36% 0.92% 0.94% 0.92% 1.07% 1.02% 1.18% 1.14% 1.89% 1.04% 1.09%
Return On Investment Capital (ROIC_SIMPLE)
- 1.03% - - - 1.80% 1.34% 1.46% 2.05% 1.64% 1.74%
Cost of Revenue to Revenue
90.63% 0.00% 92.12% 92.34% 91.01% 0.00% 91.60% 0.00% 258.30% 0.00% 91.31%
SG&A Expenses to Revenue
1.79% 2.05% 1.49% 1.49% 1.48% 1.55% 1.60% 1.42% 1.46% 1.50% 1.52%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
4.24% 96.21% 4.09% 3.97% 4.04% 95.23% 4.33% 96.05% -162.61% 95.50% 4.21%
Earnings before Interest and Taxes (EBIT)
215 167 159 162 219 217 174 183 218 218 220
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
318 272 268 270 332 330 291 304 342 344 352
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.41 3.52 2.94 3.03 3.33 3.21 3.00 3.58 3.26 3.00 3.41
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.56 0.60 0.43 0.45 0.58 0.56 0.51 0.62 0.55 0.51 0.58
Price to Earnings (P/E)
13.27 15.94 13.55 25.80 38.48 29.04 26.01 30.45 31.45 30.39 31.37
Dividend Yield
1.28% 1.20% 1.33% 1.07% 0.99% 1.04% 1.17% 0.97% 1.32% 1.19% 1.06%
Earnings Yield
7.54% 6.27% 7.38% 3.88% 2.60% 3.44% 3.85% 3.28% 3.18% 3.29% 3.19%
Enterprise Value to Invested Capital (EV/IC)
1.81 1.84 1.66 1.70 1.93 1.80 1.70 1.89 1.90 1.71 1.88
Enterprise Value to Revenue (EV/Rev)
0.85 0.95 0.72 0.73 0.85 0.87 0.83 0.94 0.81 0.82 0.87
Enterprise Value to EBITDA (EV/EBITDA)
9.69 14.92 9.58 9.63 12.62 12.77 12.01 13.39 12.04 12.06 12.56
Enterprise Value to EBIT (EV/EBIT)
13.66 24.54 15.42 15.38 20.14 20.25 19.03 21.24 19.46 19.51 20.13
Enterprise Value to NOPAT (EV/NOPAT)
27.57 31.69 20.04 19.38 29.05 27.11 25.47 28.27 25.00 26.07 26.87
Enterprise Value to Operating Cash Flow (EV/OCF)
26.72 33.41 20.29 16.33 20.28 19.24 17.68 21.95 16.32 21.28 19.37
Enterprise Value to Free Cash Flow (EV/FCFF)
4.49 5.29 4.47 4.73 34.29 26.93 37.25 85.43 47.31 196.97 53.17
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.78 2.09 2.04 2.03 1.73 1.91 2.15 2.03 1.71 1.93 1.82
Long-Term Debt to Equity
1.37 2.08 2.03 1.71 1.41 1.61 2.01 2.02 1.70 1.92 1.81
Financial Leverage
1.62 2.25 2.18 1.96 1.25 1.87 1.88 1.87 1.51 1.78 1.76
Leverage Ratio
4.73 4.61 4.60 4.29 4.37 4.23 4.39 4.27 4.18 4.15 4.29
Compound Leverage Factor
2.30 1.45 2.10 2.13 3.18 2.75 2.13 2.25 2.08 2.59 2.68
Debt to Total Capital
64.09% 67.66% 67.13% 66.94% 63.37% 65.69% 68.29% 67.02% 63.09% 65.89% 64.57%
Short-Term Debt to Total Capital
14.89% 0.47% 0.48% 10.56% 11.59% 10.46% 4.43% 0.44% 0.37% 0.38% 0.36%
Long-Term Debt to Total Capital
49.20% 67.19% 66.65% 56.38% 51.78% 55.23% 63.86% 66.58% 62.73% 65.51% 64.21%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.08% 0.09% 0.09% 0.09% 0.09% 0.11% 0.14% 0.15% 0.16% 0.27% 0.66%
Common Equity to Total Capital
35.83% 32.25% 32.78% 32.97% 36.54% 34.20% 31.57% 32.83% 36.74% 33.84% 34.78%
Debt to EBITDA
4.71 5.67 4.04 3.98 4.52 4.93 5.34 5.01 4.33 4.88 4.54
Net Debt to EBITDA
3.34 5.39 3.79 3.69 3.94 4.53 4.59 4.61 3.82 4.53 4.18
Long-Term Debt to EBITDA
3.61 5.63 4.01 3.35 3.69 4.15 4.99 4.97 4.30 4.85 4.51
Debt to NOPAT
13.39 12.05 8.44 8.00 10.39 10.47 11.32 10.57 8.99 10.54 9.70
Net Debt to NOPAT
9.51 11.45 7.93 7.42 9.07 9.62 9.73 9.73 7.93 9.80 8.95
Long-Term Debt to NOPAT
10.28 11.96 8.38 6.74 8.49 8.80 10.59 10.50 8.94 10.48 9.65
Altman Z-Score
1.50 2.08 2.21 2.19 2.01 2.07 1.96 2.15 2.10 2.12 2.21
Noncontrolling Interest Sharing Ratio
0.25% 0.27% 0.26% 0.24% 0.23% 0.30% 0.36% 0.36% 0.35% 0.56% 1.19%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.04 1.27 1.25 0.96 0.81 0.94 1.21 1.29 0.99 1.27 1.21
Quick Ratio
0.77 1.00 0.97 0.76 0.66 0.77 0.99 1.04 0.80 1.03 0.96
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
2,775 2,565 2,558 2,427 90 166 -55 -262 -108 -359 -147
Operating Cash Flow to CapEx
773.20% -590.89% 273.04% 178.85% 770.63% -498.48% 223.15% 69.56% 949.11% -651.65% 422.01%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 29.61 29.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 2.56 1.73 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 1.62 0.76 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.01 1.20 1.40 1.43 1.18 1.40 1.35 1.38 1.42 1.43 1.42
Accounts Receivable Turnover
7.81 7.37 8.58 8.67 8.56 7.98 7.92 7.84 8.59 8.00 8.25
Inventory Turnover
30.91 23.86 1.41 2.05 40.38 43.51 50.10 41.47 42.06 43.41 40.79
Fixed Asset Turnover
9.30 9.41 11.20 11.30 11.60 11.34 11.22 11.19 11.19 11.13 11.30
Accounts Payable Turnover
11.39 10.22 0.63 0.94 11.98 14.52 17.83 14.55 11.63 14.22 14.71
Days Sales Outstanding (DSO)
46.74 49.53 42.52 42.12 42.66 45.77 46.10 46.53 42.48 45.63 44.24
Days Inventory Outstanding (DIO)
11.81 15.30 259.78 178.11 9.04 8.39 7.28 8.80 8.68 8.41 8.95
Days Payable Outstanding (DPO)
32.05 35.72 581.73 386.38 30.46 25.14 20.47 25.09 31.39 25.66 24.81
Cash Conversion Cycle (CCC)
26.49 29.10 -279.43 -166.15 21.25 29.01 32.91 30.24 19.77 28.38 28.39
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
7,568 8,531 8,464 8,493 7,645 8,527 8,646 8,892 7,929 9,041 8,957
Invested Capital Turnover
1.82 1.70 2.03 2.07 2.29 2.06 2.06 2.06 2.38 2.14 2.21
Increase / (Decrease) in Invested Capital
-2,552 -2,475 -2,442 -2,310 77 -3.64 182 398 284 514 310
Enterprise Value (EV)
13,673 15,712 14,060 14,473 14,733 15,325 14,693 16,841 15,032 15,451 16,860
Market Capitalization
8,950 10,028 8,487 8,923 10,127 9,880 9,067 11,033 10,251 9,618 11,184
Book Value per Share
$14.22 $10.86 $11.02 $11.19 $11.54 $11.68 $11.39 $11.77 $11.98 $12.20 $12.48
Tangible Book Value per Share
($10.37) ($13.89) ($13.58) ($13.31) ($13.07) ($13.10) ($13.92) ($14.00) ($13.70) ($13.55) ($13.73)
Total Capital
10,363 8,826 8,820 8,929 8,318 9,011 9,567 9,393 8,568 9,481 9,432
Total Debt
6,642 5,972 5,921 5,978 5,271 5,920 6,533 6,295 5,406 6,247 6,090
Total Long-Term Debt
5,099 5,930 5,879 5,034 4,307 4,977 6,109 6,254 5,374 6,211 6,056
Net Debt
4,715 5,676 5,565 5,542 4,599 5,436 5,612 5,793 4,767 5,808 5,614
Capital Expenditures (CapEx)
120 111 81 79 133 118 115 110 124 120 95
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-194 424 356 385 -516 257 160 330 -631 375 214
Debt-free Net Working Capital (DFNWC)
1,733 720 713 821 157 741 1,080 832 7.71 814 690
Net Working Capital (NWC)
190 678 670 -123 -808 -202 656 791 -24 778 656
Net Nonoperating Expense (NNE)
20 62 63 59 45 57 66 65 89 58 61
Net Nonoperating Obligations (NNO)
3,847 5,676 5,565 5,542 4,599 5,436 5,612 5,793 4,767 5,808 5,614
Total Depreciation and Amortization (D&A)
103 106 109 108 113 113 117 122 124 126 132
Debt-free, Cash-free Net Working Capital to Revenue
-1.21% 2.56% 1.81% 1.93% -2.96% 1.46% 0.91% 1.85% -3.41% 1.99% 1.10%
Debt-free Net Working Capital to Revenue
10.78% 4.34% 3.63% 4.11% 0.90% 4.22% 6.13% 4.65% 0.04% 4.33% 3.56%
Net Working Capital to Revenue
1.18% 4.09% 3.41% -0.61% -4.64% -1.15% 3.72% 4.42% -0.13% 4.14% 3.38%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.57 $0.11 $0.20 $0.22 $0.47 $0.40 $0.23 $0.27 $0.33 $0.37 $0.39
Adjusted Weighted Average Basic Shares Outstanding
360.26M 262.05M 262.84M 263.39M 263.05M 264.88M 264.81M 262.66M 263.86M 263.13M 263.16M
Adjusted Diluted Earnings per Share
$0.57 $0.11 $0.20 $0.22 $0.47 $0.39 $0.23 $0.27 $0.33 $0.36 $0.38
Adjusted Weighted Average Diluted Shares Outstanding
363.03M 264.29M 265.28M 266.58M 266.20M 268.69M 267.42M 265.35M 267.35M 266.35M 266.39M
Adjusted Basic & Diluted Earnings per Share
$0.57 $0.00 $0.00 $0.00 $0.47 $0.00 $0.00 $0.00 $0.33 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
361.53M 262.45M 262.99M 263.45M 263.95M 265.10M 262.07M 262.85M 262.93M 262.84M 262.95M
Normalized Net Operating Profit after Tax (NOPAT)
151 91 116 117 168 162 128 137 175 155 163
Normalized NOPAT Margin
3.59% 2.06% 2.76% 2.68% 3.80% 3.57% 2.99% 2.95% 3.47% 3.20% 3.33%
Pre Tax Income Margin
2.49% 1.19% 1.73% 1.83% 3.61% 3.11% 1.97% 2.08% 2.15% 2.81% 2.80%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 1.84 1.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 1.34 1.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.90 1.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.40 0.47 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
17.00% 17.72% 17.22% 30.23% 38.05% 30.27% 30.32% 29.87% 33.95% 36.10% 33.08%
Augmented Payout Ratio
17.00% 17.72% 17.22% 30.23% 38.05% 30.27% 30.32% 29.87% 85.98% 93.64% 68.58%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, four-year look at Aramark (ARMK) based on the quarterly cashflow, income statement, and balance sheet figures you provided. The bullets highlight what looks most relevant for retail investors assessing trends and risks.

  • Total revenue has trended higher over the four-year window, rising from roughly $3.9–4.6B in 2023 to the mid-$4B range in 2024–2025, with Q1 2026 revenue at about $4.83B.
  • Net income attributable to common shareholders has improved in recent quarters, reaching about $96.2M in Q1 2026 (vs about $86.7M in Q4 2025 and roughly $71.8M in Q3 2025).
  • Operating cash flow showed solid strength in late 2024–2025, including Net cash from continuing operating activities of about $1.18B in Q4 2025, indicating stronger cash generation during that period.
  • The company pays a quarterly dividend per share of $0.12, signaling ongoing shareholder returns (Q1 2026 data).
  • Very large goodwill (~$4.89B in Q1 2026) and intangible assets (~$1.88B) reflect a history of acquisitions and asset-book growth, which can both support scale and pose impairment risk if growth slows.
  • Total liabilities (~$10.31B) compare with equity (~$3.21B), yielding a high leverage picture (roughly 3.2x debt-to-equity at the latest period), a key credit/profile consideration for investors.
  • Working capital dynamics show recurring cash use tied to operating changes, with Changes in Operating Assets and Liabilities net often negative (e.g., -$925.6M in Q1 2026), signaling cash needs tied to operating activity.
  • Net cash from continuing operating activities has been negative in several quarters (e.g., -$782.2M in Q1 2026; other quarters also show negative operating cash flow windows), highlighting cash-creation volatility.
  • Net change in cash and equivalents for some quarters has been negative (e.g., Q1 2026 net change in cash -$198.8M), despite financing inflows and significant investing activity, underscoring cash-flow variability.
  • The company has engaged in substantial debt issuance across multiple quarters (for example, Issuance of Debt around $2.51B in Q2 2025 and additional issuances in other periods), which increases interest expense and leverage risk if cash generation slows.
05/26/26 04:02 AM ETAI Generated. May Contain Errors.

Aramark Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Aramark's fiscal year ends in October. Their fiscal year 2025 ended on October 3, 2025.

In the past 10 years, Aramark's net income has ranged from -$461.44 million in 2020 to $674.11 million in 2023, and is currently $326.39 million as of their latest financial filing in 2025. Check out Aramark's forecast to explore projected trends and price targets.

Aramark's total operating income in 2025 was $791.85 million, based on the following breakdown:
  • Total Gross Profit: $1.55 billion
  • Total Operating Expenses: $754.78 million

Over the last 10 years, Aramark's total revenue changed from $14.33 billion in 2015 to $18.51 billion in 2025, a change of 29.2%.

Aramark's total liabilities were at $10.14 billion at the end of 2025, a 5.3% increase from 2024, and a 22.2% increase since 2015.

In the past 10 years, Aramark's cash and equivalents has ranged from $122.42 million in 2015 to $2.51 billion in 2020, and is currently $639.10 million as of their latest financial filing in 2025.

Over the last 10 years, Aramark's book value per share changed from 7.87 in 2015 to 11.98 in 2025, a change of 52.3%.



Financial statements for NYSE:ARMK last updated on 5/17/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners